BSE - Delayed Quote INR

J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)

1,561.90
+34.60
+(2.27%)
At close: 3:42:38 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
37,937,310
34,476,710
31,165,056
24,242,400
20,189,110
Cost of Revenue
13,160,889
12,029,489
11,847,974
8,429,400
7,174,359
Gross Profit
24,776,421
22,447,221
19,317,082
15,813,000
13,014,751
Operating Expense
16,453,971
14,920,871
13,442,194
11,105,100
8,138,884
Operating Income
8,322,450
7,526,350
5,874,888
4,707,900
4,875,867
Net Non Operating Interest Income Expense
-152,604
-399,004
-335,169
-51,200
-54,672
Pretax Income
8,589,592
7,515,092
5,552,326
5,049,000
5,968,854
Tax Provision
2,189,114
1,988,814
1,452,273
1,188,600
1,483,624
Net Income Common Stockholders
6,400,478
5,526,278
4,098,355
3,853,600
4,479,636
Diluted NI Available to Com Stockholders
6,400,478
5,526,278
4,098,355
3,853,600
4,479,636
Basic EPS
41.22
35.66
26.50
24.93
28.98
Diluted EPS
40.22
34.85
26.17
24.91
28.98
Basic Average Shares
155,243.79
154,951.52
77,325
154,576.82
154,564.19
Diluted Average Shares
159,218.13
158,587.47
78,308.80
154,700.92
154,564.19
Rent Expense Supplemental
--
20,169
29,508
13,403
11,486
Total Expenses
29,614,860
26,950,360
25,290,168
19,534,500
15,313,243
Net Income from Continuing & Discontinued Operation
6,400,478
5,526,278
4,098,355
3,853,600
4,479,636
Normalized Income
6,155,585.12
5,284,601.34
4,042,424.91
3,853,600
3,706,328.57
Interest Income
--
44,277
25,362
9,343
17,740
Interest Expense
190,119
436,519
354,084
51,200
69,429
Net Interest Income
-152,604
-399,004
-335,169
-51,200
-54,672
EBIT
8,779,711
7,951,611
5,906,410
5,100,200
6,038,283
EBITDA
10,433,115
9,334,815
7,050,479
5,826,800
6,724,938
Reconciled Cost of Revenue
13,160,889
12,029,489
11,847,974
8,429,400
7,174,359
Reconciled Depreciation
1,653,404
1,383,204
1,144,069
726,600
686,655
Net Income from Continuing Operation Net Minority Interest
6,400,478
5,526,278
4,098,355
3,853,600
4,479,636
Total Unusual Items Excluding Goodwill
328,652
328,652
75,741
374,479
1,029,102
Total Unusual Items
328,652
328,652
75,741
374,479
1,029,102
Normalized EBITDA
10,104,463
9,006,163
6,974,738
5,826,800
5,695,836
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
83,759.12
86,975.34
19,810.91
0
255,794.57
3/31/2021 - 12/11/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYNCOMF.BO Syncom Formulations (India) Limited
16.44
+9.24%
 
SUVENPHAR.NS Cohance Lifesciences Limited
1,063.30
-1.35%
 
IPCALAB.NS Ipca Laboratories Limited
1,371.60
+0.72%
 
ABBOTINDIA.BO Abbott India Limited
30,042.95
-0.35%
 
ABBOTINDIA.NS Abbott India Limited
30,065.00
-0.33%
 
CIPLA.NS Cipla Limited
1,511.60
+2.14%
 
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,195.60
+3.43%
 
EOLS Evolus, Inc.
9.80
-2.87%